279 related articles for article (PubMed ID: 1454161)
1. Tricyclic antidepressant plasma levels after fluoxetine addition.
Vandel S; Bertschy G; Bonin B; Nezelof S; François TH; Vandel B; Sechter D; Bizouard P
Neuropsychobiology; 1992; 25(4):202-7. PubMed ID: 1454161
[TBL] [Abstract][Full Text] [Related]
2. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine-imipramine interaction.
Leroi I; Walentynowicz MA
Can J Psychiatry; 1996 Jun; 41(5):318-9. PubMed ID: 8793156
[No Abstract] [Full Text] [Related]
4. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
Perry PJ; Zeilmann C; Arndt S
J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
[TBL] [Abstract][Full Text] [Related]
5. [Toxic tricyclic drug plasma level caused by fluoxetine].
Hambrecht M
Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic antidepressant-induced seizures and plasma drug concentration.
Preskorn SH; Fast GA
J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.
Pfuhlmann B; Gerlach M; Burger R; Gonska S; Unterecker S; Jabs B; Riederer P; Deckert J
J Neural Transm Suppl; 2007; (72):287-96. PubMed ID: 17982905
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic drug monitoring in depression--new perspectives].
Radziwoń-Zaleska M; Matsumoto H; Skalski M; Dziklińska A; Androsiuk W; Wakarow A; Wilkowska J; Matoszko D; Kuczyńska J; Goluch J
Psychiatr Pol; 2002; 36(6 Suppl):71-80. PubMed ID: 12647424
[TBL] [Abstract][Full Text] [Related]
9. Comorbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes.
Tollefson GD; Souetre E; Thomander L; Potvin JH
Int Clin Psychopharmacol; 1993; 8(4):281-93. PubMed ID: 8277149
[TBL] [Abstract][Full Text] [Related]
10. Metabolic interaction between fluoxetine and clomipramine: a case report.
Balant-Gorgia AE; Ries C; Balant LP
Pharmacopsychiatry; 1996 Jan; 29(1):38-41. PubMed ID: 8852534
[TBL] [Abstract][Full Text] [Related]
11. Amitriptyline absorption in a patient with short bowel syndrome.
Robbins B; Reiss RA
Am J Gastroenterol; 1999 Aug; 94(8):2302-4. PubMed ID: 10445571
[TBL] [Abstract][Full Text] [Related]
12. [Grapefruit juice as a contraindication? An approach in psychiatry].
Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
[TBL] [Abstract][Full Text] [Related]
13. Dosing of antidepressants--the unknown art.
Jerling M
J Clin Psychopharmacol; 1995 Dec; 15(6):435-9. PubMed ID: 8748433
[TBL] [Abstract][Full Text] [Related]
14. Managing rapid metabolizers of antidepressants.
Kraus RP; Diaz P; McEachran A
Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
[TBL] [Abstract][Full Text] [Related]
15. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine-TCA interaction.
March JS; Moon RL; Johnston H
J Am Acad Child Adolesc Psychiatry; 1990 Nov; 29(6):985-6. PubMed ID: 2273036
[No Abstract] [Full Text] [Related]
17. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
Vandel S; Bertschy G; Baumann P; Bouquet S; Bonin B; Francois T; Sechter D; Bizouard P
Pharmacol Res; 1995 Jun; 31(6):347-53. PubMed ID: 8685072
[TBL] [Abstract][Full Text] [Related]
18. High levels of tricyclic antidepressants in conventional therapy: determinant factors.
Tamayo M; Fernández de Gatta MM; Gutierrez JR; García MJ; Domínguez-Gil A
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):495-9. PubMed ID: 3235216
[TBL] [Abstract][Full Text] [Related]
19. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
Diaz A; Fouilloux C; Ortiz S
Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
[No Abstract] [Full Text] [Related]
20. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
Browne M; Horn E; Jones TT
Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
